R.PR
REGISTERED-PRINCIPAL REGISTER
04/09/2024
Back to search
Official data from USPTO
NUPHASE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
04/10/2024
Trademark type
Word
Nice classes
5
Filing date
08/17/2022
Registration date
04/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/09/2024
Last transaction
04/10/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
District, Beijing, CN
Examiner
VAUSS, JERAMEY
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Beijing NuPhase Therapeutics Co., Ltd.
Representatives
Kathryn E. Smith WOOD HERRON & EVANS LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations for medical purposes; medicines for the treatment of cancerimmune diseasesdiseases affecting the central nervous systemrare diseases; medicinal drinks; biochemical medicines for the treatment of cancerimmune diseasesdiseases affecting the central nervous systemrare diseases; chemical preparations for pharmaceutical purposesfor the treatment of cancerimmune diseasesdiseases affecting the central nervous systemrare diseases; pharmaceutical preparations for the treatment of cancerimmune diseasesdiseases affecting the central nervous systemrare diseases; biological tissue cultures for medical purposes; biological preparations for the treatment of cancerimmune diseasesdiseases affecting the central nervous systemrare diseases; reagent paper for medical purposes; nutraceutical preparations for therapeutic purposes or the treatment of cancerimmune diseasesdiseases affecting the central nervous systemrare diseases
Publications
History of USPTO decisions and trademark events.
23 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/09/2024
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
03/01/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/01/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
01/09/2024
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
01/09/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/17/2023
PUBO
PUBLISHED FOR OPPOSITION
10/17/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/27/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/05/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/06/2023
GNRT
NON-FINAL ACTION E-MAILED
06/06/2023
CNRT
NON-FINAL ACTION WRITTEN
06/06/2023
DOCK
ASSIGNED TO EXAMINER
06/05/2023
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
10/07/2022
ALIE
ASSIGNED TO LIE
10/07/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/07/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
08/27/2022
NWAP
NEW APPLICATION ENTERED
08/20/2022
Continuous trademark protection
Get notified about every new filing that threatens NUPHASE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.